Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (8) Bähring, Sylvia Dr. (5) Birchmeier, Walter Prof. Dr. (5) Birchmeier-Kohler, Carmen Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (9) Dechend, Ralf Priv. Doz. (4) Falcke, Martin Prof. Dr. (2) Fielitz, Jens Dr. (1) Gerhardt, Holger Prof. Dr. (1) Gotthardt, Michael Prof. Dr. (1) Höpken, Uta Elisabeth PD Dr. (2) Hübner, Norbert Prof. Dr. (5) Ivics, Zoltan Dr. (3) Izsvak, Zsuzsanna Dr. (4) Jentsch, Thomas Prof. Dr. (12) Kettenmann, Helmut Prof. Dr. (15) Kettritz, Ralph Prof. Dr. (1) Klußmann, Enno PD Dr. (2) Kocks, Christine Dr. (1) Kühn, Ralf Dr. (5) Lee, Young-Ae Prof. Dr. (2) Lewin, Gary Prof. Dr. (5) Luft, Friedrich Prof. Dr. (53) Morano, Ingo Prof. Dr. (11) Müller, Dominik Prof. Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Rahn, Hans-Peter Dr. (1) Rajewsky, Klaus Prof. Dr. (2) Rajewsky, Nikolaus Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (1) Sander, Maike Prof. Dr. (2) Scheidereit, Claus Prof. Dr. (4) Spuler, Simone Prof. (3) Walther, Wolfgang Prof. Dr. (7) Wanker, Erich Prof. Dr. (4) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (4) Wolf, Jana Prof. Dr. (2) (-) Leutz, Achim Prof. Dr. (4) (-) Stein, Ulrike Prof. Dr. (7) Translationale Onkologie solider Tumore (7) 1991 (1) 1992 (3) 1993 (4) 1994 (12) 1995 (4) 1996 (9) (-) 1997 (11) 1998 (7) 1999 (7) 2000 (9) 2001 (8) 2002 (14) 2003 (7) 2004 (12) 2005 (9) 2006 (14) 2007 (7) 2009 (17) 2010 (18) 2011 (19) 2012 (19) 2013 (21) 2014 (12) 2015 (18) 2016 (17) 2017 (17) 2018 (15) 2019 (18) 2020 (27) 2021 (23) 2022 (32) 2023 (20) 2024 (18) 11 Ergebnisse: Active Filter: Leutz, Achim Prof. Dr.Stein, Ulrike Prof. Dr.1997 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste November 1997 / J Mol Med B-Myb, a repressed trans-activating protein S. Ansieau E. Kowenz-Leutz R. Dechend A. Leutz 01. Januar 1997 / Biotechniques In situ RT-PCR using fluorescence-labeled primers U. Stein W. Walther J. Wendt T.A. Schild 01. Januar 1997 / J Natl Cancer Inst Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP U. Stein W. Walther C.M. Laurencot G.L. Scheffer R.J. Scheper R.H. Shoemaker 01. Januar 1997 / Int J Cancer Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo U. Stein W. Walther M. Lemm H. Naundorf I. Fichtner 01. Januar 1997 / Gene Ther Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy W. Walther J. Wendt U. Stein 01. Januar 1997 / Proc Am Assoc Cancer Res Diverse effects of tumor necrosis factor a on expression of the multidrug resistance-associated genes LRP and MRP U. Stein W. Walther C.M. Laurencot G.L. Scheffer R.J. Scheper R.H. Shoemaker 01. Januar 1997 / Proc Am Assoc Cancer Res Development and characterization of novel multidrug resistant breast cancer lines W. Walther U. Stein M. Lemm H. Naundorf I. Fichtner 01. Januar 1997 Modulation of MDR1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug U. Stein W. Walther R.H. Shoemaker 30. September 1997 / Proc Natl Acad Sci U S A Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein P. Dhordain O. Albagli R.J. Lin S. Ansieau S. Quief A. Leutz J.P. Kerckaert R.M. Evans D. Leprince 01. Januar 1997 / Cell The homeobox gene GBX2, a target of the myb oncogene, mediates autocrine growth and monocyte differentiation E. Kowenz-Leutz P. Herr K. Niss A. Leutz Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
November 1997 / J Mol Med B-Myb, a repressed trans-activating protein S. Ansieau E. Kowenz-Leutz R. Dechend A. Leutz
01. Januar 1997 / Biotechniques In situ RT-PCR using fluorescence-labeled primers U. Stein W. Walther J. Wendt T.A. Schild
01. Januar 1997 / J Natl Cancer Inst Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP U. Stein W. Walther C.M. Laurencot G.L. Scheffer R.J. Scheper R.H. Shoemaker
01. Januar 1997 / Int J Cancer Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo U. Stein W. Walther M. Lemm H. Naundorf I. Fichtner
01. Januar 1997 / Gene Ther Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy W. Walther J. Wendt U. Stein
01. Januar 1997 / Proc Am Assoc Cancer Res Diverse effects of tumor necrosis factor a on expression of the multidrug resistance-associated genes LRP and MRP U. Stein W. Walther C.M. Laurencot G.L. Scheffer R.J. Scheper R.H. Shoemaker
01. Januar 1997 / Proc Am Assoc Cancer Res Development and characterization of novel multidrug resistant breast cancer lines W. Walther U. Stein M. Lemm H. Naundorf I. Fichtner
01. Januar 1997 Modulation of MDR1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug U. Stein W. Walther R.H. Shoemaker
30. September 1997 / Proc Natl Acad Sci U S A Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein P. Dhordain O. Albagli R.J. Lin S. Ansieau S. Quief A. Leutz J.P. Kerckaert R.M. Evans D. Leprince
01. Januar 1997 / Cell The homeobox gene GBX2, a target of the myb oncogene, mediates autocrine growth and monocyte differentiation E. Kowenz-Leutz P. Herr K. Niss A. Leutz